▶ 調査レポート

世界のモンテルカスト薬市場 2021:企業別、地域別、種類・用途別

• 英文タイトル:Global Montelukast Drug Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

GlobalInfoResearchが調査・発行した産業分析レポートです。世界のモンテルカスト薬市場 2021:企業別、地域別、種類・用途別 / Global Montelukast Drug Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026 / GIR-2104Z09570資料のイメージです。• レポートコード:GIR-2104Z09570
• 出版社/出版日:GlobalInfoResearch / 2021年4月
※2025年版があります。お問い合わせください。

• レポート形態:英文、PDF、135ページ
• 納品方法:Eメール(納期:2~3日)
• 産業分類:医療・医薬品
• 販売価格(消費税別)
  Single User¥504,600 (USD3,480)▷ お問い合わせ
  Multi User¥756,900 (USD5,220)▷ お問い合わせ
  Corporate User¥1,009,200 (USD6,960)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
当調査資料では、モンテルカスト薬のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。モンテルカスト薬の種類別市場規模(錠剤、経口用顆粒)、用途別市場規模(病院、ドラッグストア、その他)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・モンテルカスト薬の市場概要
・企業情報(企業概要、製品概要、販売量、価格、売上):Merck & Co.、Teva、Mylan、Glenmark Pharmaceuticals、Hikma Group、Sandoz、Torrent Pharmaceuticals、Lannett Company、Apotex、Dr. Reddys Laboratories、Aurobindo Pharma、Accord Healthcare、Hetero、Unimark、Ajanta Pharma、MACLEODS、Jubilant Pharma、Unichem Laboratories、Amneal Pharmaceuticals、Shanghai Anbison Lab、Perrigo、Cipla、CSPC Ouyi Pharmaceutical
・企業別市場シェア
・地域別市場分析2016年-2026年
・種類別分析2016年-2026年:錠剤、経口用顆粒
・用途別分析2016年-2026年:病院、ドラッグストア、その他
・モンテルカスト薬の北米市場規模2016年-2026年:アメリカ、カナダ、メキシコ
・モンテルカスト薬のヨーロッパ市場規模2016年-2026年:ドイツ、イギリス、フランス、ロシア、イタリア
・モンテルカスト薬のアジア市場規模2016年-2026年:中国、日本、韓国、インド、東南アジア、オーストラリア
・モンテルカスト薬の南米市場規模2016年-2026年:ブラジル、アルゼンチン
・モンテルカスト薬の中東・アフリカ市場規模2016年-2026年:サウジアラビア、トルコ、エジプト、南アフリカ
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Montelukast Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Montelukast Drug size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Montelukast Drug market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Montelukast Drug market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Tablets
Oral Granules

Market segment by Application can be divided into
Hospital
Drug Store
Others

The key market players for global Montelukast Drug market are listed below:
Merck & Co.
Teva
Mylan
Glenmark Pharmaceuticals
Hikma Group
Sandoz
Torrent Pharmaceuticals
Lannett Company
Apotex
Dr. Reddys Laboratories
Aurobindo Pharma
Accord Healthcare
Hetero
Unimark
Ajanta Pharma
MACLEODS
Jubilant Pharma
Unichem Laboratories
Amneal Pharmaceuticals
Shanghai Anbison Lab
Perrigo
Cipla
CSPC Ouyi Pharmaceutical

Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

レポート目次

1 Market Overview
1.1 Montelukast Drug Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Montelukast Drug Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Tablets
1.2.3 Oral Granules
1.3 Market Analysis by Application
1.3.1 Overview: Global Montelukast Drug Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Hospital
1.3.3 Drug Store
1.3.4 Others
1.4 Global Montelukast Drug Market Size & Forecast
1.4.1 Global Montelukast Drug Sales in Value (2016-2026))
1.4.2 Global Montelukast Drug Sales in Volume (2016-2026)
1.4.3 Global Montelukast Drug Price by Type (2016-2026) & (USD/Unit)
1.5 Global Montelukast Drug Production Capacity Analysis
1.5.1 Global Montelukast Drug Total Production Capacity (2016-2026)
1.5.2 Global Montelukast Drug Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Montelukast Drug Market Drivers
1.6.2 Montelukast Drug Market Restraints
1.6.3 Montelukast Drug Trends Analysis
2 Manufacturers Profiles
2.1 Merck & Co.
2.1.1 Merck & Co. Details
2.1.2 Merck & Co. Major Business
2.1.3 Merck & Co. Montelukast Drug Product and Services
2.1.4 Merck & Co. Montelukast Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Teva
2.2.1 Teva Details
2.2.2 Teva Major Business
2.2.3 Teva Montelukast Drug Product and Services
2.2.4 Teva Montelukast Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Mylan
2.3.1 Mylan Details
2.3.2 Mylan Major Business
2.3.3 Mylan Montelukast Drug Product and Services
2.3.4 Mylan Montelukast Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Glenmark Pharmaceuticals
2.4.1 Glenmark Pharmaceuticals Details
2.4.2 Glenmark Pharmaceuticals Major Business
2.4.3 Glenmark Pharmaceuticals Montelukast Drug Product and Services
2.4.4 Glenmark Pharmaceuticals Montelukast Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Hikma Group
2.5.1 Hikma Group Details
2.5.2 Hikma Group Major Business
2.5.3 Hikma Group Montelukast Drug Product and Services
2.5.4 Hikma Group Montelukast Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 Sandoz
2.6.1 Sandoz Details
2.6.2 Sandoz Major Business
2.6.3 Sandoz Montelukast Drug Product and Services
2.6.4 Sandoz Montelukast Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 Torrent Pharmaceuticals
2.7.1 Torrent Pharmaceuticals Details
2.7.2 Torrent Pharmaceuticals Major Business
2.7.3 Torrent Pharmaceuticals Montelukast Drug Product and Services
2.7.4 Torrent Pharmaceuticals Montelukast Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.8 Lannett Company
2.8.1 Lannett Company Details
2.8.2 Lannett Company Major Business
2.8.3 Lannett Company Montelukast Drug Product and Services
2.8.4 Lannett Company Montelukast Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.9 Apotex
2.9.1 Apotex Details
2.9.2 Apotex Major Business
2.9.3 Apotex Montelukast Drug Product and Services
2.9.4 Apotex Montelukast Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.10 Dr. Reddys Laboratories
2.10.1 Dr. Reddys Laboratories Details
2.10.2 Dr. Reddys Laboratories Major Business
2.10.3 Dr. Reddys Laboratories Montelukast Drug Product and Services
2.10.4 Dr. Reddys Laboratories Montelukast Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.11 Aurobindo Pharma
2.11.1 Aurobindo Pharma Details
2.11.2 Aurobindo Pharma Major Business
2.11.3 Aurobindo Pharma Montelukast Drug Product and Services
2.11.4 Aurobindo Pharma Montelukast Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.12 Accord Healthcare
2.12.1 Accord Healthcare Details
2.12.2 Accord Healthcare Major Business
2.12.3 Accord Healthcare Montelukast Drug Product and Services
2.12.4 Accord Healthcare Montelukast Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.13 Hetero
2.13.1 Hetero Details
2.13.2 Hetero Major Business
2.13.3 Hetero Montelukast Drug Product and Services
2.13.4 Hetero Montelukast Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.14 Unimark
2.14.1 Unimark Details
2.14.2 Unimark Major Business
2.14.3 Unimark Montelukast Drug Product and Services
2.14.4 Unimark Montelukast Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.15 Ajanta Pharma
2.15.1 Ajanta Pharma Details
2.15.2 Ajanta Pharma Major Business
2.15.3 Ajanta Pharma Montelukast Drug Product and Services
2.15.4 Ajanta Pharma Montelukast Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.16 MACLEODS
2.16.1 MACLEODS Details
2.16.2 MACLEODS Major Business
2.16.3 MACLEODS Montelukast Drug Product and Services
2.16.4 MACLEODS Montelukast Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.17 Jubilant Pharma
2.17.1 Jubilant Pharma Details
2.17.2 Jubilant Pharma Major Business
2.17.3 Jubilant Pharma Montelukast Drug Product and Services
2.17.4 Jubilant Pharma Montelukast Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.18 Unichem Laboratories
2.18.1 Unichem Laboratories Details
2.18.2 Unichem Laboratories Major Business
2.18.3 Unichem Laboratories Montelukast Drug Product and Services
2.18.4 Unichem Laboratories Montelukast Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.19 Amneal Pharmaceuticals
2.19.1 Amneal Pharmaceuticals Details
2.19.2 Amneal Pharmaceuticals Major Business
2.19.3 Amneal Pharmaceuticals Montelukast Drug Product and Services
2.19.4 Amneal Pharmaceuticals Montelukast Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.20 Shanghai Anbison Lab
2.20.1 Shanghai Anbison Lab Details
2.20.2 Shanghai Anbison Lab Major Business
2.20.3 Shanghai Anbison Lab Montelukast Drug Product and Services
2.20.4 Shanghai Anbison Lab Montelukast Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.21 Perrigo
2.21.1 Perrigo Details
2.21.2 Perrigo Major Business
2.21.3 Perrigo Montelukast Drug Product and Services
2.21.4 Perrigo Montelukast Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.22 Cipla
2.22.1 Cipla Details
2.22.2 Cipla Major Business
2.22.3 Cipla Montelukast Drug Product and Services
2.22.4 Cipla Montelukast Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.23 CSPC Ouyi Pharmaceutical
2.23.1 CSPC Ouyi Pharmaceutical Details
2.23.2 CSPC Ouyi Pharmaceutical Major Business
2.23.3 CSPC Ouyi Pharmaceutical Montelukast Drug Product and Services
2.23.4 CSPC Ouyi Pharmaceutical Montelukast Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Montelukast Drug Sales by Manufacturer
3.1 Global Montelukast Drug Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Montelukast Drug Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Montelukast Drug
3.4 Market Concentration Rate
3.4.1 Top 3 Montelukast Drug Manufacturer Market Share
3.4.2 Top 6 Montelukast Drug Manufacturer Market Share
3.5 Global Montelukast Drug Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Montelukast Drug Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Montelukast Drug Market Size by Region
4.1.1 Global Montelukast Drug Sales in Volume by Region (2016-2026)
4.1.2 Global Montelukast Drug Revenue by Region (2016-2026)
4.2 North America Montelukast Drug Revenue (2016-2026)
4.3 Europe Montelukast Drug Revenue (2016-2026)
4.4 Asia-Pacific Montelukast Drug Revenue (2016-2026)
4.5 South America Montelukast Drug Revenue (2016-2026)
4.6 Middle East and Africa Montelukast Drug Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Montelukast Drug Sales in Volume by Type (2016-2026)
5.2 Global Montelukast Drug Revenue by Type (2016-2026)
5.3 Global Montelukast Drug Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Montelukast Drug Sales in Volume by Application (2016-2026)
6.2 Global Montelukast Drug Revenue by Application (2016-2026)
6.3 Global Montelukast Drug Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Montelukast Drug Sales by Type (2016-2026)
7.2 North America Montelukast Drug Sales by Application (2016-2026)
7.3 North America Montelukast Drug Market Size by Country
7.3.1 North America Montelukast Drug Sales in Volume by Country (2016-2026)
7.3.2 North America Montelukast Drug Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Montelukast Drug Sales by Type (2016-2026)
8.2 Europe Montelukast Drug Sales by Application (2016-2026)
8.3 Europe Montelukast Drug Market Size by Country
8.3.1 Europe Montelukast Drug Sales in Volume by Country (2016-2026)
8.3.2 Europe Montelukast Drug Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Montelukast Drug Sales by Type (2016-2026)
9.2 Asia-Pacific Montelukast Drug Sales by Application (2016-2026)
9.3 Asia-Pacific Montelukast Drug Market Size by Region
9.3.1 Asia-Pacific Montelukast Drug Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Montelukast Drug Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Montelukast Drug Sales by Type (2016-2026)
10.2 South America Montelukast Drug Sales by Application (2016-2026)
10.3 South America Montelukast Drug Market Size by Country
10.3.1 South America Montelukast Drug Sales in Volume by Country (2016-2026)
10.3.2 South America Montelukast Drug Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Montelukast Drug Sales by Type (2016-2026)
11.2 Middle East & Africa Montelukast Drug Sales by Application (2016-2026)
11.3 Middle East & Africa Montelukast Drug Market Size by Country
11.3.1 Middle East & Africa Montelukast Drug Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Montelukast Drug Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Montelukast Drug Typical Distributors
12.3 Montelukast Drug Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

List of Tables
Table 1. Global Montelukast Drug Revenue by Type, (USD Million), 2021-2026
Table 2. Global Montelukast Drug Revenue by Application, (USD Million), 2021-2026
Table 3. Merck & Co. Basic Information, Manufacturing Base and Competitors
Table 4. Merck & Co. Major Business
Table 5. Merck & Co. Montelukast Drug Product and Services
Table 6. Merck & Co. Montelukast Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Teva Basic Information, Manufacturing Base and Competitors
Table 8. Teva Major Business
Table 9. Teva Montelukast Drug Product and Services
Table 10. Teva Montelukast Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Mylan Basic Information, Manufacturing Base and Competitors
Table 12. Mylan Major Business
Table 13. Mylan Montelukast Drug Product and Services
Table 14. Mylan Montelukast Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Glenmark Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 16. Glenmark Pharmaceuticals Major Business
Table 17. Glenmark Pharmaceuticals Montelukast Drug Product and Services
Table 18. Glenmark Pharmaceuticals Montelukast Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Hikma Group Basic Information, Manufacturing Base and Competitors
Table 20. Hikma Group Major Business
Table 21. Hikma Group Montelukast Drug Product and Services
Table 22. Hikma Group Montelukast Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Sandoz Basic Information, Manufacturing Base and Competitors
Table 24. Sandoz Major Business
Table 25. Sandoz Montelukast Drug Product and Services
Table 26. Sandoz Montelukast Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Torrent Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 28. Torrent Pharmaceuticals Major Business
Table 29. Torrent Pharmaceuticals Montelukast Drug Product and Services
Table 30. Torrent Pharmaceuticals Montelukast Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Lannett Company Basic Information, Manufacturing Base and Competitors
Table 32. Lannett Company Major Business
Table 33. Lannett Company Montelukast Drug Product and Services
Table 34. Lannett Company Montelukast Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Apotex Basic Information, Manufacturing Base and Competitors
Table 36. Apotex Major Business
Table 37. Apotex Montelukast Drug Product and Services
Table 38. Apotex Montelukast Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Dr. Reddys Laboratories Basic Information, Manufacturing Base and Competitors
Table 40. Dr. Reddys Laboratories Major Business
Table 41. Dr. Reddys Laboratories Montelukast Drug Product and Services
Table 42. Dr. Reddys Laboratories Montelukast Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Aurobindo Pharma Basic Information, Manufacturing Base and Competitors
Table 44. Aurobindo Pharma Major Business
Table 45. Aurobindo Pharma Montelukast Drug Product and Services
Table 46. Aurobindo Pharma Montelukast Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Accord Healthcare Basic Information, Manufacturing Base and Competitors
Table 48. Accord Healthcare Major Business
Table 49. Accord Healthcare Montelukast Drug Product and Services
Table 50. Accord Healthcare Montelukast Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. Hetero Basic Information, Manufacturing Base and Competitors
Table 52. Hetero Major Business
Table 53. Hetero Montelukast Drug Product and Services
Table 54. Hetero Montelukast Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 55. Unimark Basic Information, Manufacturing Base and Competitors
Table 56. Unimark Major Business
Table 57. Unimark Montelukast Drug Product and Services
Table 58. Unimark Montelukast Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 59. Ajanta Pharma Basic Information, Manufacturing Base and Competitors
Table 60. Ajanta Pharma Major Business
Table 61. Ajanta Pharma Montelukast Drug Product and Services
Table 62. Ajanta Pharma Montelukast Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 63. MACLEODS Basic Information, Manufacturing Base and Competitors
Table 64. MACLEODS Major Business
Table 65. MACLEODS Montelukast Drug Product and Services
Table 66. MACLEODS Montelukast Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 67. Jubilant Pharma Basic Information, Manufacturing Base and Competitors
Table 68. Jubilant Pharma Major Business
Table 69. Jubilant Pharma Montelukast Drug Product and Services
Table 70. Jubilant Pharma Montelukast Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 71. Unichem Laboratories Basic Information, Manufacturing Base and Competitors
Table 72. Unichem Laboratories Major Business
Table 73. Unichem Laboratories Montelukast Drug Product and Services
Table 74. Unichem Laboratories Montelukast Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 75. Amneal Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 76. Amneal Pharmaceuticals Major Business
Table 77. Amneal Pharmaceuticals Montelukast Drug Product and Services
Table 78. Amneal Pharmaceuticals Montelukast Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 79. Shanghai Anbison Lab Basic Information, Manufacturing Base and Competitors
Table 80. Shanghai Anbison Lab Major Business
Table 81. Shanghai Anbison Lab Montelukast Drug Product and Services
Table 82. Shanghai Anbison Lab Montelukast Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 83. Perrigo Basic Information, Manufacturing Base and Competitors
Table 84. Perrigo Major Business
Table 85. Perrigo Montelukast Drug Product and Services
Table 86. Perrigo Montelukast Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 87. Cipla Basic Information, Manufacturing Base and Competitors
Table 88. Cipla Major Business
Table 89. Cipla Montelukast Drug Product and Services
Table 90. Cipla Montelukast Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 91. CSPC Ouyi Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 92. CSPC Ouyi Pharmaceutical Major Business
Table 93. CSPC Ouyi Pharmaceutical Montelukast Drug Product and Services
Table 94. CSPC Ouyi Pharmaceutical Montelukast Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 95. Global Montelukast Drug Sales by Manufacturer (2019-2021e) & (K Units)
Table 96. Global Montelukast Drug Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 97. Market Position of Manufacturers in Montelukast Drug, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 98. Global Montelukast Drug Production Capacity by Company, (K Units): 2020 VS 2021
Table 99. Head Office and Montelukast Drug Production Site of Key Manufacturer
Table 100. Global Montelukast Drug Sales by Region (2016-2021e) & (K Units)
Table 101. Global Montelukast Drug Sales by Region (2021-2026) & (K Units)
Table 102. Global Montelukast Drug Revenue by Region (2016-2021e) & (USD Million)
Table 103. Global Montelukast Drug Revenue by Region (2021-2026) & (USD Million)
Table 104. Global Montelukast Drug Sales by Type (2016-2021e) & (K Units)
Table 105. Global Montelukast Drug Sales by Type (2021-2026) & (K Units)
Table 106. Global Montelukast Drug Revenue by Type (2016-2021e) & (USD Million)
Table 107. Global Montelukast Drug Revenue by Type (2021-2026) & (USD Million)
Table 108. Global Montelukast Drug Price by Type (2016-2021e) & (USD/Unit)
Table 109. Global Montelukast Drug Price by Type (2021-2026) & (USD/Unit)
Table 110. Global Montelukast Drug Sales by Application (2016-2021e) & (K Units)
Table 111. Global Montelukast Drug Sales by Application (2021-2026) & (K Units)
Table 112. Global Montelukast Drug Revenue by Application (2016-2021e) & (USD Million)
Table 113. Global Montelukast Drug Revenue by Application (2021-2026) & (USD Million)
Table 114. Global Montelukast Drug Price by Application (2016-2021e) & (USD/Unit)
Table 115. Global Montelukast Drug Price by Application (2021-2026) & (USD/Unit)
Table 116. North America Montelukast Drug Sales by Country (2016-2021e) & (K Units)
Table 117. North America Montelukast Drug Sales by Country (2021-2026) & (K Units)
Table 118. North America Montelukast Drug Revenue by Country (2016-2021e) & (USD Million)
Table 119. North America Montelukast Drug Revenue by Country (2021-2026) & (USD Million)
Table 120. North America Montelukast Drug Sales by Type (2016-2021e) & (K Units)
Table 121. North America Montelukast Drug Sales by Type (2021-2026) & (K Units)
Table 122. North America Montelukast Drug Sales by Application (2016-2021e) & (K Units)
Table 123. North America Montelukast Drug Sales by Application (2021-2026) & (K Units)
Table 124. Europe Montelukast Drug Sales by Country (2016-2021e) & (K Units)
Table 125. Europe Montelukast Drug Sales by Country (2021-2026) & (K Units)
Table 126. Europe Montelukast Drug Revenue by Country (2016-2021e) & (USD Million)
Table 127. Europe Montelukast Drug Revenue by Country (2021-2026) & (USD Million)
Table 128. Europe Montelukast Drug Sales by Type (2016-2021e) & (K Units)
Table 129. Europe Montelukast Drug Sales by Type (2021-2026) & (K Units)
Table 130. Europe Montelukast Drug Sales by Application (2016-2021e) & (K Units)
Table 131. Europe Montelukast Drug Sales by Application (2021-2026) & (K Units)
Table 132. Asia-Pacific Montelukast Drug Sales by Region (2016-2021e) & (K Units)
Table 133. Asia-Pacific Montelukast Drug Sales by Region (2021-2026) & (K Units)
Table 134. Asia-Pacific Montelukast Drug Revenue by Region (2016-2021e) & (USD Million)
Table 135. Asia-Pacific Montelukast Drug Revenue by Region (2021-2026) & (USD Million)
Table 136. Asia-Pacific Montelukast Drug Sales by Type (2016-2021e) & (K Units)
Table 137. Asia-Pacific Montelukast Drug Sales by Type (2021-2026) & (K Units)
Table 138. Asia-Pacific Montelukast Drug Sales by Application (2016-2021e) & (K Units)
Table 139. Asia-Pacific Montelukast Drug Sales by Application (2021-2026) & (K Units)
Table 140. South America Montelukast Drug Sales by Country (2016-2021e) & (K Units)
Table 141. South America Montelukast Drug Sales by Country (2021-2026) & (K Units)
Table 142. South America Montelukast Drug Revenue by Country (2016-2021e) & (USD Million)
Table 143. South America Montelukast Drug Revenue by Country (2021-2026) & (USD Million)
Table 144. South America Montelukast Drug Sales by Type (2016-2021e) & (K Units)
Table 145. South America Montelukast Drug Sales by Type (2021-2026) & (K Units)
Table 146. South America Montelukast Drug Sales by Application (2016-2021e) & (K Units)
Table 147. South America Montelukast Drug Sales by Application (2021-2026) & (K Units)
Table 148. Middle East & Africa Montelukast Drug Sales by Country (2016-2021e) & (K Units)
Table 149. Middle East & Africa Montelukast Drug Sales by Country (2021-2026) & (K Units)
Table 150. Middle East & Africa Montelukast Drug Revenue by Country (2016-2021e) & (USD Million)
Table 151. Middle East & Africa Montelukast Drug Revenue by Country (2021-2026) & (USD Million)
Table 152. Middle East & Africa Montelukast Drug Sales by Type (2016-2021e) & (K Units)
Table 153. Middle East & Africa Montelukast Drug Sales by Type (2021-2026) & (K Units)
Table 154. Middle East & Africa Montelukast Drug Sales by Application (2016-2021e) & (K Units)
Table 155. Middle East & Africa Montelukast Drug Sales by Application (2021-2026) & (K Units)
Table 156. Direct Channel Pros & Cons
Table 157. Indirect Channel Pros & Cons
Table 158. Montelukast Drug Typical Distributors
Table 159. Montelukast Drug Typical Customers
List of Figures
Figure 1. Montelukast Drug Picture
Figure 2. Global Montelukast Drug Sales Market Share by Type in 2020
Figure 3. Tablets
Figure 4. Oral Granules
Figure 5. Global Montelukast Drug Sales Market Share by Application in 2020
Figure 6. Hospital
Figure 7. Drug Store
Figure 8. Others
Figure 9. Global Montelukast Drug Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 10. Global Montelukast Drug Market Size and Forecast (2016-2026) & (USD Million)
Figure 11. United States Montelukast Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 12. Canada Montelukast Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 13. Mexico Montelukast Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. Germany Montelukast Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. France Montelukast Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. United Kingdom Montelukast Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. Russia Montelukast Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. Italy Montelukast Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. China Montelukast Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Japan Montelukast Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. Korea Montelukast Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. India Montelukast Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Southeast Asia Montelukast Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Australia Montelukast Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Brazil Montelukast Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Egypt Montelukast Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Saudi Arabia Montelukast Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. South Africa Montelukast Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Turkey Montelukast Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Global Montelukast Drug Sales (2016-2026) & (K Units)
Figure 31. Global Montelukast Drug Production Capacity (2016-2026) & (K Units)
Figure 32. Global Montelukast Drug Production Capacity by Geographic Region: 2020 VS 2021
Figure 33. Montelukast Drug Market Drivers
Figure 34. Montelukast Drug Market Restraints
Figure 35. Montelukast Drug Market Trends
Figure 36. Global Montelukast Drug Sales Market Share by Manufacturer in 2020
Figure 37. Global Montelukast Drug Revenue Market Share by Manufacturer in 2020
Figure 38. Montelukast Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 39. Top 3 Montelukast Drug Manufacturer (Revenue) Market Share in 2020
Figure 40. Top 6 Montelukast Drug Manufacturer (Revenue) Market Share in 2020
Figure 41. Global Montelukast Drug Sales Market Share by Region (2016-2026)
Figure 42. Global Montelukast Drug Revenue Market Share by Region (2016-2026)
Figure 43. North America Montelukast Drug Revenue (2016-2026) & (USD Million)
Figure 44. Europe Montelukast Drug Revenue (2016-2026) & (USD Million)
Figure 45. Asia-Pacific Montelukast Drug Revenue (2016-2026) & (USD Million)
Figure 46. South America Montelukast Drug Revenue (2016-2026) & (USD Million)
Figure 47. Middle East & Africa Montelukast Drug Revenue (2016-2026) & (USD Million)
Figure 48. Global Montelukast Drug Sales Market Share by Type (2016-2026)
Figure 49. Global Montelukast Drug Revenue Market Share by Type (2016-2026)
Figure 50. Global Montelukast Drug Price by Type (2016-2026) & (USD/Unit)
Figure 51. Global Montelukast Drug Sales Market Share by Application (2016-2026)
Figure 52. Global Montelukast Drug Revenue Market Share by Application (2016-2026)
Figure 53. Global Montelukast Drug Price by Application (2016-2026) & (USD/Unit)
Figure 54. North America Montelukast Drug Sales Market Share by Country (2016-2026)
Figure 55. North America Montelukast Drug Revenue Market Share by Country (2016-2026)
Figure 56. North America Montelukast Drug Sales Market Share by Type (2016-2026)
Figure 57. North America Montelukast Drug Sales Market Share by Application (2016-2026)
Figure 58. Europe Montelukast Drug Sales Market Share by Country (2016-2026)
Figure 59. Europe Montelukast Drug Revenue Market Share by Country (2016-2026)
Figure 60. Europe Montelukast Drug Sales Market Share by Type (2016-2026)
Figure 61. Europe Montelukast Drug Sales Market Share by Application (2016-2026)
Figure 62. Asia-Pacific Montelukast Drug Sales Market Share by Region (2016-2026)
Figure 63. Asia-Pacific Montelukast Drug Revenue Market Share by Region (2016-2026)
Figure 64. Asia-Pacific Montelukast Drug Sales Market Share by Region (2016-2026)
Figure 65. Asia-Pacific Montelukast Drug Sales Market Share by Application (2016-2026)
Figure 66. South America Montelukast Drug Sales Market Share by Country (2016-2026)
Figure 67. South America Montelukast Drug Revenue Market Share by Country (2016-2026)
Figure 68. South America Montelukast Drug Sales Market Share by Type (2016-2026)
Figure 69. South America Montelukast Drug Sales Market Share by Application (2016-2026)
Figure 70. Middle East & Africa Montelukast Drug Sales Market Share by Country (2016-2026)
Figure 71. Middle East & Africa Montelukast Drug Revenue Market Share by Country (2016-2026)
Figure 72. Middle East & Africa Montelukast Drug Sales Market Share by Type (2016-2026)
Figure 73. Middle East & Africa Montelukast Drug Sales Market Share by Application (2016-2026)
Figure 74. Sales Channel: Direct Channel vs Indirect Channel
Figure 75. Methodology
Figure 76. Research Process and Data Source